About: Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $15.47 (-3.49%)
DYN NASDAQ Dyne Therapeutics Inc
Dyne Therapeutics Inc share price
Atividade de preço de DYN
Último preço
$ 15,470
Variação (24h)
-0,56 USD (3,49%)
Volume
1.66M
Volume (média 4 sem.)
-
Abertura
$ 15,91
Variação do dia
$ 15,41 - $ 16,48
Fechamento anterior
$ 16,03
Último negócio
20 Nov, 8:59 pm GMT+0
Atrasado
20 Nov, 8:59 pm GMT+0
DYN price performance
Atrasado
20 Nov, 8:59 pm GMT+0
DYN details
quote.marketSignals